The Reveos® SELECT set is intended to collect a unit of whole blood and to process the whole blood unit on the Reveos Automated Blood Processing System, producing blood components.

Rx only.

70 mL Citrate Phosphate Dextrose (CPD) anticoagulant is a sterile solution in a PVC plasticized with DEHP bag. Each 70 mL of CPD contains: Dextrose (anhydrous) 1.624 g, Trisodium Citrate (dihydrate) 1.841 g, Citric Acid (monohydrate) 0.229 g, Sodium Dihydrogen Phosphate (dihydrate) 0.176 g, and water for injection up to 70 mL.

111 mL Additive Solution 5 (AS-5) red cell preservative solution is a sterile solution in a PVC plasticized with DEHP bag. Each 111 mL of AS-5 contains: Dextrose (anhydrous) 0.908 g, Sodium Chloride 0.973 g, Mannitol 0.583 g, Adenine 0.035 g, and water for injection up to 111 mL.

None.

• Single-use product. Do not reuse. This product is intended to be single use only and is not intended to be reused or re-sterilized in any manner. Terumo Blood and Cell Technologies cannot ensure the functionality or sterility of the product if it is reused or re-sterilized. Reuse of a single-use disposable set may result in:
  • Product performance issues due to loss of product integrity, including but not limited to the following:
    • Fluid leaks
    • Parts that are warped or deformed
    • Plastics that are brittle and discolored
    • Filters that have reduced filtration capabilities
  • Viral infections such as hepatitis or human immunodeficiency virus (HIV)
  • Bacterial infections
  • Cross-contamination
  Any of these risks could result in serious injury or death. These risks are shared by product users, donors, patients, and recipients of the end product of the device.
• Inspect the packaging and the blood bag set prior to use. Do not use the set if any of the following conditions are present:
  • There are tears or holes in the outer aluminum foil packaging or in the individual transparent packaging wrap.
  • The tubing has severe kinks.
  • The blood bag set is incorrectly assembled.
  • The blood bag set is defective or damaged, or there are any leaks from the fluid-filled components of the set.
  • Any clamps are closed.
  • The needle cap is not in place.
  • The solutions are cloudy or discolored or contain particulates.
  Using the blood bag set under these conditions may result in product contamination or poor performance during collection and/or processing.
  Note: It is normal to have some condensation in the outer aluminum foil pouch and individual transparent packaging wrap due to sterilization.
• The blood bag set is no longer sterile if any of the following conditions occur:
  • You disconnect the sample/diversion bag before you seal the sample/diversion tubing.
  • You remove blood samples before you seal the sample/diversion tubing.
  • The integrity of the set is compromised for any reason.
  Manage the blood bag set according to your institution's SOP.
• Do not process whole blood less than 2 hours after collection. Processing blood too soon after collection may result in incomplete RBC leukoreduction and/or a reduced platelet yield.
• Residual leukocytes are a by-product of the processing procedure and contain mostly white blood cells (WBC), with some plasma, platelets, and red blood cells (RBC). Residual leukocytes are not intended for transfusion.
• Use aseptic technique during blood collection to ensure donor safety and product quality.
• Do not vent the blood bag set.

To report SUSPECTED ADVERSE REACTIONS, contact Terumo BCT, Inc. at 1-877-339-4228 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

The Reveos SELECT set has not been adequately studied in controlled clinical trials with specific populations.

The Reveos SELECT set has been evaluated for use with the Reveos system.

The blood and fluid pathways of the blood bag set are steam-sterilized and are non-pyrogenic.

The blood bag set is intended for use by appropriately trained phlebotomists who collect whole blood and by blood center personnel who process whole blood using the Reveos system.

The formulas of the active ingredients are provided in Tables 1 and 2.

Each 70 mL of CPD contains: Dextrose (anhydrous) 1.624 g, Trisodium Citrate (dihydrate) 1.841 g, Citric Acid (monohydrate) 0.229 g, Sodium Dihydrogen Phosphate (dihydrate) 0.176 g, and water for injection up to 70 mL.

Each 111 mL of AS-5 contains: Dextrose (anhydrous) 0.908 g, Sodium Chloride 0.973 g, Mannitol 0.583 g, Adenine 0.035 g, and water for injection up to 111 mL.

The PVC plasticized with DEHP bags are not made with natural rubber latex.

The bags contain materials that have been tested to demonstrate the suitability of the containers for storing pharmaceutical solutions. The bags are nontoxic and biologically inert. The blood bag set is a closed system and is not dependent upon entry of external air during administration. The blood bag set is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.

The blood bag sets are packaged in outer aluminum foil pouches. Each outer aluminum foil pouch contains 2 blood bag sets. Each case contains 8 outer aluminum foil pouches.

Issued: February 2023

Manufactured by:
TERUMO BCT Vietnam CO., Ltd.
Long Duc Industrial Park, Long Duc Commune,
Long Thanh District, Dong Nai Province, Vietnam

For:
Terumo BCT, Inc.
10811 W. Collins Ave.
Lakewood, CO 80215

If for any reason this product must be returned to Terumo BCT, Inc., a returned goods authorization (an RGA number) is required from Terumo BCT prior to shipping. Instructions for cleaning and materials, including appropriate shipping containers, proper labeling, and an RGA number, may be obtained from the Terumo BCT Quality Assurance Department. IT IS THE RESPONSIBILITY OF THE HEALTH CARE INSTITUTION TO ADEQUATELY PREPARE AND IDENTIFY THE PRODUCT FOR RETURN SHIPMENT. Please contact your local representative for information regarding returned goods and product complaints.

Tubing Specifications (non-sterile, nominal* dimensions)

* Note: The tubing dimensions listed on this document are nominal values and are intended for use in determining compatibility with various types of laboratory equipment. The nominal values are specified target dimensions; however, because they are based on non‑sterile tubing measurements, and due to variations in the manufacturing process, the actual dimensions may be slightly different.
		Description	Primary tubing	Sample tube holder/luer adapter tubing
		Item(s)	1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14	3
		Wall Thickness	0.7 mm	1.3 mm
		Outer Diameter	4.4 mm	4.4 mm
		Inner Diameter	3.0 mm	1.8 mm

Tubing Set Composition

• Primary tubing: Polyvinyl chloride (PVC) plasticized with Di(2-ethylhexyl)phthalate (DEHP)
• Bags: PVC plasticized with DEHP
• RBC leukoreduction filter: PVC plasticized with DEHP housing, polybutylterephthalate media
• Access needle: Stainless steel (contains cobalt)
• Needle injury protector (NIP): Polypropylene (PP)
• Sample tube holder/luer adapter: PVC/polycarbonate housing, stainless steel needle
• Clamps: Polyacetal
• Cross-connector: PVC

Not made with natural rubber latex.

This product may be covered by one or more patents or pending patent applications.

See TERUMOBCT.COM/patents for details.

Terumo BCT, Inc. ("Terumo Blood and Cell Technologies", "Terumo BCT")

TERUMO Reveos® SELECT

CPD/AS-5 RED CELL PRESERVATIVE SOLUTION FOR COLLECTION OF 500mL OF BLOOD

CAUTIONS:

For single use only. Sterile fluid path, sterilized
using steam. Non-pyrogenic fluid path.

Do not re-sterilize.

Read the instructions carefully before use.

Do not use if package is damaged.

Store between 1°C and 30°C

Manufactured by :

TERUMO BCT Vietnam Co., Ltd.

Long Duc Industrial Park, Long Duc Commune,
Long Thanh District, Dong Nai Province, Vietnam

For :

TERUMO BCT, Inc.

10811 W. Collins ave.
Lakewood, CO 80215

Rx ONLY

D0000036575-A

XXXX

LOT : LOT #

MFG DATE : Date of Mfg.

EXPIRY DATE : Exp. Date

CAT. NO. : 6FO506A0

UNITS : 016

NDC : 82906-506-16

NDC (ISBT 128)